FDA Allows Generic Version of Scarce J&J Cancer DrugFDA Allows Generic Version of Scarce J&J Cancer DrugFederal regulators say approval of the first generic version of cancer drug Doxil will help resolve a lingering shortage triggered by manufacturing deficiencies.Associated PressAssociated Press